» Articles » PMID: 39683545

Effects of Pterostilbene on the Cell Division Cycle of a Neuroblastoma Cell Line

Overview
Journal Nutrients
Date 2024 Dec 17
PMID 39683545
Authors
Affiliations
Soon will be listed here.
Abstract

The "Cell Cycle Hypothesis" suggests that the abnormal re-entry of neurons into the cell division cycle leads to neurodegeneration, a mechanism supported by in vitro studies on neuronal-like cells treated with the hyperphosphorylating agent forskolin. Pterostilbene, a bioavailable compound found in foods such as blueberries and grapes, may exert neuroprotective effects and could serve as a potential adjunct therapy for neurodegenerative diseases. . In this study, we investigated the effects of pterostilbene on neuronal-like cells derived from the human neuroblastoma SK-N-BE cell line, where cell cycle reactivation was induced by forskolin treatment. We analyzed molecular endpoints associated with differentiated versus replicative cell states, specifically the following: (a) the expression of cyclin , (b) the Ki67 cell proliferation marker, (c) the AT8 nuclear tau epitope, and (d) genome-wide DNA methylation changes. . Our findings indicate that pterostilbene exerts distinct effects on the cell division cycle depending on the cellular state, with neuroprotective benefits observed in differentiated neuronal-like cells, but not in cells undergoing induced division. Additionally, pterostilbene alters DNA methylation patterns. These results suggest that pterostilbene may offer neuroprotective advantages for differentiated neuronal-like cells. However, further studies are required to confirm these effects in vivo by examining specific biomarkers in human populations consuming pterostilbene-containing foods.

References
1.
Leotta C, Federico C, Brundo M, Tosi S, Saccone S . HLXB9 gene expression, and nuclear location during in vitro neuronal differentiation in the SK-N-BE neuroblastoma cell line. PLoS One. 2014; 9(8):e105481. PMC: 4138170. DOI: 10.1371/journal.pone.0105481. View

2.
Fernandez-Santiago R, Merkel A, Castellano G, Heath S, Raya A, Tolosa E . Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson's disease patients. Clin Epigenetics. 2019; 11(1):108. PMC: 6651999. DOI: 10.1186/s13148-019-0701-6. View

3.
Joseph C, Mangani A, Gupta V, Chitranshi N, Shen T, Dheer Y . Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development. Aging Dis. 2020; 11(4):946-966. PMC: 7390532. DOI: 10.14336/AD.2019.0923. View

4.
Zhang M, Tang Z . Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation. Biomed Pharmacother. 2023; 161:114474. DOI: 10.1016/j.biopha.2023.114474. View

5.
Behrens M, Lendon C, Roe C . A common biological mechanism in cancer and Alzheimer's disease?. Curr Alzheimer Res. 2009; 6(3):196-204. PMC: 2810550. DOI: 10.2174/156720509788486608. View